Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Aviation & Aerospace

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758868

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758868

Space Medicines

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Space Medicines Market to Reach US$1.6 Billion by 2030

The global market for Space Medicines estimated at US$922.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private Aerospace Service, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$937.9 Million by the end of the analysis period. Growth in the Non-Private Aerospace Service segment is estimated at 12.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$242.6 Million While China is Forecast to Grow at 9.2% CAGR

The Space Medicines market in the U.S. is estimated at US$242.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.3 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Space Medicines Market - Key Trends & Drivers Summarized

Why Are Space Medicines Gaining Strategic Relevance in Astronaut Health, Long-Duration Missions, and Microgravity-Driven Biomedical Innovation?

Space medicines are becoming increasingly critical as space agencies and private operators prepare for prolonged missions to the Moon, Mars, and beyond. These medicines are specifically designed or repurposed to address health challenges unique to the space environment, including microgravity-induced physiological changes, radiation exposure, compromised immunity, fluid redistribution, and muscle and bone loss. As human presence in space extends in both duration and destination, space medicines are emerging as a key enabler of mission sustainability, crew safety, and autonomous healthcare delivery in remote orbital habitats.

The market encompasses a broad range of pharmaceutical formulations, delivery systems, and biomedical countermeasures tailored for space conditions. It also includes diagnostic tools and therapeutic protocols developed through spaceflight research, many of which offer potential translational value for treating diseases on Earth. With space now viewed as a frontier for biomedical discovery, space medicine is positioned at the intersection of aerospace innovation and advanced healthcare.

How Are Drug Stability, Delivery Technologies, and Spaceflight Biology Shaping Medical Preparedness for Space Missions?

Key advancements are focused on maintaining drug efficacy in extreme conditions-vacuum, temperature fluctuations, and radiation exposure-all of which can degrade pharmaceutical compounds during long-term storage. Stability testing, packaging innovation, and lyophilization are being optimized to ensure shelf life for critical medications in space.

Novel drug delivery systems such as transdermal patches, orally disintegrating tablets, and intranasal sprays are being adapted to overcome microgravity-related challenges in administration. Injections and intravenous treatments are also under study for space-safe reconstitution and usage. Telemedicine and AI-driven diagnostics are being integrated to support in-mission treatment without real-time Earth-based medical intervention.

Research into microgravity’s impact on cell function, gene expression, and disease modeling is also revealing unique pathways for drug discovery-particularly in the areas of immunology, musculoskeletal degeneration, neurovestibular conditions, and accelerated aging. These insights are advancing development of space-optimized therapeutics that may have dual applications on Earth, especially in geriatric and chronic disease care.

Which Missions and Regional Programs Are Driving Demand and Innovation in Space Medicines?

Space medicines are primarily developed and tested through partnerships with national space agencies, academic institutions, and biotech companies engaged in spaceflight research. The International Space Station (ISS) remains the most active platform for pharmaceutical testing and health countermeasure evaluation. Upcoming Moon missions under Artemis and planned Mars expeditions are expanding the need for autonomous medical solutions and broader pharmaceutical inventories.

The United States leads in funding and institutional infrastructure, driven by NASA’s Human Research Program and collaboration with NIH and commercial partners. Europe contributes through ESA-sponsored experiments and cross-border consortia in biomedical research. Japan, China, and India are advancing their own research agendas via national labs and extended human spaceflight programs, increasingly incorporating space medicine into mission architecture. In the private sector, commercial spaceflight operators and biotech firms are investing in zero-gravity R&D to advance both astronaut care and Earth-based healthcare applications.

What Are the Factors Driving Growth in the Space Medicines Market?

The space medicines market is expanding as human spaceflight enters a new era of long-duration habitation, commercial exploration, and interplanetary ambition. The need to manage medical conditions autonomously, ensure pharmaceutical stability, and maintain crew functionality over extended missions is driving both demand and innovation in this niche yet strategically vital domain.

Key growth drivers include increased human spaceflight missions, rising investment in space health R&D, dual-use medical innovation opportunities, and international collaboration in life sciences research. The development of self-contained medical systems, biologics stability protocols, and space-adapted diagnostics is further positioning space medicine as a frontier of both aerospace readiness and medical advancement.

As humanity prepares for deeper and longer journeys into space, could space medicines redefine not only astronaut health but also the future of personalized, resilient, and extreme-environment healthcare on Earth?

SCOPE OF STUDY:

The report analyzes the Space Medicines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Private Aerospace Service, Non-Private Aerospace Service); Application (Oncology, Regeneration Medicine, Neurobiology, Microbiology, Other Applications); End-User (Commercial, Government, Military, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Baylor College of Medicine - Center for Space Medicine
  • BioOrbit
  • Blue Origin
  • Delta Biosciences
  • European Space Agency - Space Medicine Office
  • InnovaSpace
  • Institute of Biomedical Problems (IBMP)
  • Japan Aerospace Exploration Agency (JAXA) - Space Medicine
  • Nanotics
  • Orbital Medicine
  • Redwire Space
  • ResearchSat
  • SEAC Space Academy
  • Space Medical Accelerator
  • SpacePharma
  • SpaceTech Analytics
  • SpaceX
  • Translational Research Institute for Space Health (TRISH)
  • Varda Space Industries
  • Voyager Space

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP35804

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Space Medicines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Interest in Long-Duration Space Missions and Human Spaceflight Health Throws the Spotlight on Space Medicines
    • Growth in ISS Research and Private Space Habitats Spurs Demand for Microgravity-Optimized Pharmaceutical Solutions
    • Development of Radiation-Resistant, Thermally Stable, and Extended Shelf-Life Medications Supports In-Space Use
    • Focus on Countermeasures for Bone Loss, Muscle Atrophy, and Immune Suppression Enhances Astronaut Health Protocols
    • Integration of 3D Bioprinting, On-Demand Drug Synthesis, and Portable Compounding Units Enables In-Situ Pharmaceutical Production
    • Rising Inclusion of Spaceflight Stressors in Drug Efficacy Studies Promotes Dual-Use Development
    • Commercialization of Space-Validated Drugs for Earth Applications Expands Technology Transfer Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Space Medicines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Space Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Space Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Private Aerospace Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Private Aerospace Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Non-Private Aerospace Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Non-Private Aerospace Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Military by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Military by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Government by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Government by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Regeneration Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Regeneration Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurobiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurobiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • CHINA
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Space Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Space Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Space Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Space Medicines by Type - Private Aerospace Service and Non-Private Aerospace Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Space Medicines by Type - Percentage Breakdown of Value Sales for Private Aerospace Service and Non-Private Aerospace Service for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Space Medicines by End-user - Military, Other End-Users, Commercial and Government - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Space Medicines by End-user - Percentage Breakdown of Value Sales for Military, Other End-Users, Commercial and Government for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Space Medicines by Application - Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Space Medicines by Application - Percentage Breakdown of Value Sales for Oncology, Regeneration Medicine, Neurobiology, Microbiology and Other Applications for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!